Vir Biotechnology VIR
$ 6.95
3.12%
Quarterly report 2024-Q3
added 11-04-2024
Vir Biotechnology Financial Ratios 2011-2024 | VIR
Annual Financial Ratios Vir Biotechnology
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.6 | 5.9 | 10.3 | -10.7 | -4.1 | - | - | - | - | - | - | - | - |
P/S |
18.5 | 1.9 | 5.0 | 41.8 | 88.3 | - | - | - | - | - | - | - | - |
EPS |
-4.6 | 3.9 | 4.1 | -2.5 | -5.8 | -15.1 | -32.5 | - | - | - | - | - | - |
EV (Enterprise Value) |
1.68 B | 2.92 B | 5.61 B | 2.96 B | 693 M | 323 M | 132 M | - | - | - | - | - | - |
EBITDA per Share |
-4.96 | 6.33 | 3.28 | -2.46 | -5.72 | - | - | - | - | - | - | - | - |
EV/EBITDA |
12.9 | -26487.9 | -3.5 | - | - | - | - | - | - | - | - | ||
PEG |
- | -271.98 | 0.01 | - | - | - | - | - | - | - | - | ||
P/B |
1.0 | 1.5 | 3.8 | 4.5 | 1.7 | - | - | - | - | - | - | - | - |
P/CF |
-2.0 | 1.8 | -114.3 | -16.7 | -5.2 | - | - | - | - | - | - | - | - |
ROE % |
-38.68 | 24.82 | 36.92 | -41.66 | -41.20 | - | - | - | - | - | - | - | - |
ROA % |
-32.05 | 18.41 | 27.05 | -32.51 | -34.11 | - | - | - | - | - | - | - | - |
ROCE % |
-43.03 | 40.09 | 29.39 | -41.43 | -39.30 | - | - | - | - | - | - | - | - |
Current Ratio |
5.8 | 3.9 | 3.7 | 4.6 | 6.8 | - | - | - | - | - | - | - | - |
DSO |
13.8 | 87.6 | 128.8 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
841.9 | 16.1 | 32.1 | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
13.8 | 87.6 | 128.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-828.2 | 71.5 | 96.7 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Vir Biotechnology
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.56 | -1.02 | -0.48 | - | -1.22 | -1.45 | -1.06 | - | 1.32 | -0.58 | 3.93 | - | 0.85 | 0.48 | -1.32 | -0.83 | -0.67 | -0.27 | -0.71 | -0.69 | -4.6 | -3.64 | -3.19 | -3.05 | -4.16 | -3.35 | -4.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.67 | -1.13 | -0.56 | - | -1.36 | -1.57 | -1.03 | - | 1.48 | -1.69 | 7.69 | - | -0.4 | 0.48 | -1.23 | - | -0.69 | -0.24 | -0.65 | - | -4.45 | -3.75 | -3.34 | - | -4.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-40.85 | -33.38 | -34.49 | -27.67 | -19.51 | -1.60 | 5.24 | 30.15 | 42.76 | 47.20 | 59.51 | -4.96 | -19.70 | -44.11 | -56.84 | -41.66 | -41.97 | -41.56 | -45.22 | -41.20 | -11.43 | 18.64 | 46.63 | 53.39 | 38.66 | 19.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-34.18 | -27.91 | -28.30 | -21.96 | -15.46 | -0.96 | 4.80 | 21.55 | 30.67 | 33.29 | 42.06 | 0.10 | -11.40 | -29.74 | -38.97 | -32.51 | -33.46 | -33.69 | -36.92 | -34.11 | -35.43 | -43.46 | -36.84 | -31.24 | -17.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-46.03 | -38.54 | -39.36 | -30.31 | -21.24 | -1.02 | -0.68 | 48.20 | 42.10 | 26.94 | 46.76 | -22.19 | -34.41 | -40.54 | -52.87 | -26.31 | -37.55 | -36.58 | -40.96 | -26.94 | -7.77 | 22.64 | 31.08 | 19.17 | 19.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
5.8 | 7.1 | 7.3 | 5.8 | 5.5 | 5.2 | 3.8 | 3.9 | 4.9 | 3.9 | 3.3 | 3.7 | 3.6 | 3.3 | 2.3 | 4.5 | 4.5 | 4.5 | 4.5 | 5.8 | 5.8 | 5.8 | 5.8 | 3.1 | 3.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | 0.8 | -1381.4 | 73.9 | - | 41.0 | 29.0 | 2597.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
10670.8 | 10092.8 | 10399.4 | - | 19197.3 | 50832.5 | 444.3 | - | 27.4 | 35.2 | 8.8 | - | 88.8 | 587.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | 0.8 | -1381.4 | 73.9 | - | 41.0 | 29.0 | 2597.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-10670.8 | -10092.8 | -10399.4 | - | -19197.3 | -50832.5 | -444.3 | - | -26.5 | -1416.7 | 65.1 | - | -47.9 | -558.6 | 2597.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency